Turn this role into an interview — a resume and cover letter built around what this employer wants.
Johnson & Johnson is hiring a Senior Financial Analyst, Consolidations, to join the International Consolidations team in Bangalore. The role supports intercompany eliminations, consolidation entries, and preparation of consolidated financial statements for multiple regions.
The candidate should have a 4–6 year track record in finance or accounting, strong Excel skills, and familiarity with IFRS/US GAAP; travel minimal may be required.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com .
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
DePuy Synthes is recruiting for a Senior Financial Analyst, Consolidations, to join our newly formed International (OUS) Consolidations team.
The Senior Financial Analyst, Consolidations supports the accurate and timely preparation of consolidated financial results for DePuy Synthes across four regions (EMEA, APAC, LATAM and Canada). This role plays an important part in ensuring financial integrity across legal entities by supporting consolidation activities, variance analysis, and reporting and analytics. The position offers exposure to global finance operations, with opportunities to build strong reporting expertise within a complex, multinational organization.
Johnson & Johnson announced plans to separate our Orthopaedics business to establish a standalone orthopaedics company, operating as DePuy Synthes. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals. Should you accept this position, it is anticipated that, following conclusion of the transaction, you would be an employee of DePuy Synthes and your employment would be governed by DePuy Synthes employment processes, programs, policies, and benefit plans. In that case, details of any planned changes would be provided to you